Identification of Selective Small Molecule Inhibitors of the Nucleotide-Binding Oligomerization Domain 1 (NOD1) Signaling Pathway

por Rickard, David J., Sehon, Clark A., Kasparcova, Viera, Kallal, Lorena A., Haile, Pamela A., Zeng, Xin, Montoute, Monica N., Poore, Derek D., Li, Hu, Wu, Zining, Eidam, Patrick M., Emery, John G., Marquis, Robert W., Gough, Peter J., Bertin, John
Publicado 2014

MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses

por Yu, Jong W., Hoffman, Sandy, Beal, Allison M., Dykon, Angela, Ringenberg, Michael A., Hughes, Anna C., Dare, Lauren, Anderson, Amber D., Finger, Joshua, Kasparcova, Viera, Rickard, David, Berger, Scott B., Ramanjulu, Joshi, Emery, John G., Gough, Peter J., Bertin, John, Foley, Kevin P.
Publicado 2015

Identification of Benzimidazole Diamides as Selective Inhibitors of the Nucleotide-Binding Oligomerization Domain 2 (NOD2) Signaling Pathway

por Rickard, David J., Sehon, Clark A., Kasparcova, Viera, Kallal, Lorena A., Zeng, Xin, Montoute, Monica N., Chordia, Tushar, Poore, Derek D., Li, Hu, Wu, Zining, Eidam, Patrick M., Haile, Pamela A., Yu, Jong, Emery, John G., Marquis, Robert W., Gough, Peter J., Bertin, John
Publicado 2013

Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer

por Harris, Philip A., Marinis, Jill M., Lich, John D., Berger, Scott B., Chirala, Anirudh, Cox, Julie A., Eidam, Patrick M., Finger, Joshua N., Gough, Peter J., Jeong, Jae U., Kang, James, Kasparcova, Viera, Leister, Lara K., Mahajan, Mukesh K., Miller, George, Nagilla, Rakesh, Ouellette, Michael T., Reilly, Michael A., Rendina, Alan R., Rivera, Elizabeth J., Sun, Helen H., Thorpe, James H., Totoritis, Rachel D., Wang, Wei, Wu, Dongling, Zhang, Daohua, Bertin, John, Marquis, Robert W.
Publicado 2019